T-105 recalls

The FDA has published 2 recalls involving T-105 since 2022. The latest was reported on 4 May 2022. Most were for undeclared sulfites. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls2since 2022

Last 12 months0reported

Class I00% of total

Ongoing0latest 4 May 2022

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 0 0%Class II 1 50%Class III 1 50%

Why t-105 is recalled

Undeclared Sulfites150%
Manufacturing (CGMP) Deviations150%

Companies

Olympia Compounding Pharmacy2100%

By year

20222100%

All t-105 recalls, newest first

2 total

Reported	Class	Recall	Company	Reason	Where
4 May 2022Drug	CLASS II	T-105, Papaverine 30mg/mL . Phentolamine 1mg/ml . PGE recalled	Olympia Compounding Pharmacy	Manufacturing (CGMP) Deviations	Nationwide
30 Mar 2022Drug	CLASS III	T-105, Papaverine 30 mg/mL Phentolamine 1 mg/mL PGE recalled	Olympia Compounding Pharmacy	Undeclared Sulfites	Nationwide

Should you stop taking T-105?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.